dermagency

dermagency Zeroca 81 Serum

Ingredient analysis and how the ad lines read

Product photo of dermagency Zeroca 81 Serum

Read on 2026-09-07

What is this product?

dermagency's Zeroca 81 Serum is a 30ml peptide-and-centella serum registered in Korea as a functional cosmetic (the specific function is not itemized in the sourced record) built on niacinamide, madecassoside, asiaticoside and nine distinct sh-oligopeptide and sh-polypeptide entries, all at undisclosed concentrations. Its 'trouble-out' marketing tag is only half-earned: the soothing chemistry (niacinamide, centella actives, beta-glucan) is genuinely there, but no acne-clearing acid backs the blemish-fighting half of that name.

What makes it different?

Nine separate sh-oligopeptide and sh-polypeptide entries sit in the back third of the ingredient list, an unusually wide peptide roster for this category, though every one of them, like every other named active, carries no disclosed concentration. It is sold in a 30ml bundle configuration whose exact contents could not be confirmed here.

What is in it?

The full ingredient list as the brand publishes it, in the printed order. Each name links to what we know about that ingredient.

This brand publishes its ingredient list in Korean only. Names below are the matching INCI names from the Korean Cosmetic Association ingredient dictionary.

Key ingredient

Ingredients with no mark are ones we found nothing notable about, and when marks overlap on one ingredient we show the caution first.

We could not place these in the list above: Ceteareth Olivate, Sorbitan Olivate

Did the ad claims hold up?

We checked the one line this product advertises against the ingredient list and public documents. One of them looks likely, though none are proven outright.

Claims translated from Korean, originals preserved.

likely, not proven1

  • TroubleOUT
    Korean original

    트러블OUT

Each line is quoted as the brand published it, and each one was read on its own against the ingredient list and the documents the brand publishes.

How we read these lines